In contrast the expression of NKX3.1, a prostatic tumor suppressor gene that is down-regulated in a large proportion of high-grade PCa, increased following MCT2 knock-down (Figure 4E). The gene discussed is SLC16A7; the disease is posterior cortical atrophy.